<code id='A04E8F2760'></code><style id='A04E8F2760'></style>
    • <acronym id='A04E8F2760'></acronym>
      <center id='A04E8F2760'><center id='A04E8F2760'><tfoot id='A04E8F2760'></tfoot></center><abbr id='A04E8F2760'><dir id='A04E8F2760'><tfoot id='A04E8F2760'></tfoot><noframes id='A04E8F2760'>

    • <optgroup id='A04E8F2760'><strike id='A04E8F2760'><sup id='A04E8F2760'></sup></strike><code id='A04E8F2760'></code></optgroup>
        1. <b id='A04E8F2760'><label id='A04E8F2760'><select id='A04E8F2760'><dt id='A04E8F2760'><span id='A04E8F2760'></span></dt></select></label></b><u id='A04E8F2760'></u>
          <i id='A04E8F2760'><strike id='A04E8F2760'><tt id='A04E8F2760'><pre id='A04E8F2760'></pre></tt></strike></i>

          focus

          focus

          author:knowledge    Page View:8
          Brain cancer
          Michelle Monje/Stanford University/NIH

          Tocagen (TOCA) said Tuesday that a Phase 3 clinical trial involving a novel gene therapy for aggressive brain tumors will continue to a final analysis later this year, following an interim look at patient survival data conducted by independent monitors. Tocagen’s stock price dropped sharply.

          The San Diego-based biotech pitched the study’s continuation as an encouraging sign for its gene therapy called Toca 511/Toca FC, which is designed to deliver a localized chemotherapy directly to the site of brain tumors.

          advertisement

          “We believe the longer-term follow-up of patients in the final analysis, particularly for those randomized in the second enrollment period, will be important in assessing both primary and secondary endpoints,” said Tocagen CEO Marty Duvall, in a statement.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more
          Bulgari apologizes to China for listing Taiwan as a country after online backlash
          Bulgari apologizes to China for listing Taiwan as a country after online backlash

          1:28AwomanwalksbytheBulgaristoreatahigh-endshoppingmallinBeijing,Wednesday,July12,2023.Italianluxury

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

          2:13FILE-TheburnedremainsofahomedestroyedbytheMarshallFireareshown,Jan.7,2022,inLouisville,Colo.OnTh